Monell Chemical Senses Center

Monell Chemical Senses Center, a tax-exempt nonprofit research institute in Philadelphia, Pennsylvania, operates as a federal grant recipient focused on basic and translational research on taste, smell, gut sensing, and chemesthetic perception. The center delivers specialized chemosensory testing, human and animal research services, and scientific expertise to federal health and agriculture agencies as a prime grant recipient (83% of recent awards) and as a subrecipient on collaborative research grants.

Monell's federal footprint is concentrated in National Institutes of Health (NIH) grant work. The top five funding entities account for 75% of recent awards: NIH broadly (43 awards), the National Institute on Deafness and Other Communication Disorders (41 awards, dominant by count), the Animal and Plant Health Inspection Service (26 awards), the National Institute of Diabetes and Digestive and Kidney Diseases (15 awards), and the Army (7 awards). By potential value, the National Institute on Alcohol Abuse and Alcoholism leads with three awards carrying $140 thousand combined, followed by the NIH Office of Logistics and Acquisition Operations with one award valued at $109 thousand. Recent prime contract work includes a $60 thousand firm fixed-price purchase order from NIAAA awarded March 2026 for alcohol and chemosensory perception testing in human twins at the Twinsburg Twin Festival, a $15 thousand purchase order from NICHD for manuscript support services, and a $40 thousand NIAAA purchase order from September 2023 for chemosensory perception testing and assembly of proprietary Monell Flavor Quiz kits—a sole-source designation reflecting Monell's unique capabilities in standardized chemosensory measurement tools.

Federal grant activity from NIH institutes dominates recent awards and reflects the center's research mission. Representative prime grant recipients include a $2.65 million five-year clinical research center grant from NIDCD (March 2026) investigating inflammation and chemosensory loss following COVID-19 infection, with three integrated research projects and an administrative core focused on participant recruitment and standardized testing; a $656 thousand five-year NIDCD project grant (May 2026) on influenza virus-induced long-term anosmia and neuroinflammation mechanisms in olfactory tissue; a $579 thousand five-year NIDCD project grant (March 2026) examining molecular genetic mechanisms of food texture perception using Drosophila; a $1.49 million NIDDK project grant (September 2025) investigating neural mechanisms underlying GLP-1 receptor-mediated satiety and weight loss; and a $532 thousand five-year National Institute on Aging project grant (September 2025) supporting the Monell Scientist Entrepreneurial Program for Healthy Aging, which trains six graduate students and postdoctoral researchers annually in commercialization of smell loss biomarkers. Additional NIH grant work spans Parkinson's disease biomarkers in olfactory mucus, biophysical models of human olfactory intensity perception, chemosensory testing methodology validation, salt taste perception in individuals with smell loss, and hedonic brain circuitry research. Monell also serves as a subrecipient on collaborative grants with prime grantees including the University of Pennsylvania, Georgia State University, Tulane University, Stanford, Northwestern, University of North Carolina, New York University, and Colorado State University, providing experimental design, neurophysiological measurement, data analysis, sample processing, and chemosensory testing services.

The center's core research capabilities center on human and animal chemosensory assessment using proprietary sensory testing tools (the Monell Flavor Quiz, the Scentinel smell test), electrophysiology and calcium imaging, molecular and genetic analysis, organoid development, behavioral assays, and statistical analysis of sensory perception data. The center conducts research on the neural mechanisms of taste, smell, and interoception; feeding behavior and obesity; gastrointestinal mechanosensation; post-viral chemosensory dysfunction; and disease biomarker discovery through olfactory pathways. Activity has grown from six awards per year in 2022–2023 to sixteen in 2024, with nine new awards in 2025 and thirteen in 2026, reflecting sustained expansion in NIH-funded research collaborations. Six awards carrying combined potential value of $60 thousand reach ultimate completion within the next twenty-four months, representing recompete opportunity for related chemosensory research initiatives. Service Contract Inventory reporting is minimal: the dataset shows 0.1 FTEs delivered on two subcontract records in FY2024, reflecting the center's characterization as a research entity operating primarily under federal grant mechanisms rather than service contracts above the $150,000 SCI threshold.